Date Published:
2010
Citation-Indexed Journal:
Human and Experimental Toxicology. Volume 29, Issue 3, March 2010, Pages 153-160
Citation:
Incidence of adverse drug reactions induced by N-acetylcysteine in patients with acetaminophen overdose
Authors:
Zyoud, S.H.,
Awang, R.,
Syed Sulaiman, S.A.,
Sweileh, W.M.,
Al-Jabi, S.W.
Awang, R.,
Syed Sulaiman, S.A.,
Sweileh, W.M.,
Al-Jabi, S.W.
Abstract:
Objective:
Intravenous N-acetylcysteine (IV-NAC) is widely recognized as the antidote of choice for acetaminophen overdose. However, its use is not without adverse drug reactions (ADR) that might affect therapeutic outcome or lead to treatment delay.
Objective:
The aim of this study was to investigate the type and incidence of ADR induced by IV-NAC in patients treated for acetaminophen overdose.
Methods:
This is a retrospective study of patients admitted to the hospital for acute acetaminophen overdose over a period of 4 years (1 January 2005 to 31 December 2008). The primary outcome of interest in this study was the occurrence of ADR during NAC administration. Pearson chi-square test or Fishers exact test, students t test, and Mann-Whitney U test were used in univariate analysis. SPSS 15 was used for data analysis.
Results:
Two hundred and fifty five patients were studied. Different types of ADR were observed in 119 (46.7%) cases. Of those patients, 83 (69.7%) had been treated with IV-NAC versus 36 (30.3%) who had not (p <.001). The following ADR were significantly associated with IV-NAC administration: vomiting (p =.001), flushing (p <.001), rash (p <.001), pruritus (p <.001), chest pain (p =.001), bronchospasm (p =.03), coughing (p =.01), headache (p =.001), dizziness (p <.001), convulsion (p =.03), and hypotension (p =.001). ADR were mild in 54 (43.2%), moderate in 17 (13.6%), and severe in 12 (9.6%) patients. There were no ADR in 42 (33.6%) patients. Comparative results of the characteristics of patients who reacted to IV-NAC and nonreactors showed that patients with ADR had no significant difference in age, gender, ethnicity, amount ingested, latency time, and acetaminophen level than nonreactors.
Conclusion:
ADR to IV-NAC were common among patients with acetaminophen overdose, but mostly minor and all reported adverse reactions were easily managed.
Intravenous N-acetylcysteine (IV-NAC) is widely recognized as the antidote of choice for acetaminophen overdose. However, its use is not without adverse drug reactions (ADR) that might affect therapeutic outcome or lead to treatment delay.
Objective:
The aim of this study was to investigate the type and incidence of ADR induced by IV-NAC in patients treated for acetaminophen overdose.
Methods:
This is a retrospective study of patients admitted to the hospital for acute acetaminophen overdose over a period of 4 years (1 January 2005 to 31 December 2008). The primary outcome of interest in this study was the occurrence of ADR during NAC administration. Pearson chi-square test or Fishers exact test, students t test, and Mann-Whitney U test were used in univariate analysis. SPSS 15 was used for data analysis.
Results:
Two hundred and fifty five patients were studied. Different types of ADR were observed in 119 (46.7%) cases. Of those patients, 83 (69.7%) had been treated with IV-NAC versus 36 (30.3%) who had not (p <.001). The following ADR were significantly associated with IV-NAC administration: vomiting (p =.001), flushing (p <.001), rash (p <.001), pruritus (p <.001), chest pain (p =.001), bronchospasm (p =.03), coughing (p =.01), headache (p =.001), dizziness (p <.001), convulsion (p =.03), and hypotension (p =.001). ADR were mild in 54 (43.2%), moderate in 17 (13.6%), and severe in 12 (9.6%) patients. There were no ADR in 42 (33.6%) patients. Comparative results of the characteristics of patients who reacted to IV-NAC and nonreactors showed that patients with ADR had no significant difference in age, gender, ethnicity, amount ingested, latency time, and acetaminophen level than nonreactors.
Conclusion:
ADR to IV-NAC were common among patients with acetaminophen overdose, but mostly minor and all reported adverse reactions were easily managed.
